MoviPrep Taste

How does MoviPrep taste?

MoviPrep is lemon flavored, although you probably won’t mistake it for fresh-squeezed lemonade. The reason it tastes the way it does is because a colonoscopy prep requires certain ingredients to make it work as safely and effectively as possible.

The goal is to clean out your colon, and to that end, MoviPrep works! In fact, it works so well that it’s the #1-prescribed branded colonoscopy prep in the United States.1 MoviPrep earned this ranking because it gives doctors confidence that it will thoroughly cleanse your colon,2 allowing them to detect and remove abnormal growths (colon polyps) that may otherwise turn into cancer.

While people will have varying opinions about its taste, MoviPrep may provide a more tolerable experience compared to polyethylene glycol (PEG)–based colonoscopy preps that require you to drink 4 liters of PEG. You only have to drink 2 liters of PEG with MoviPrep plus an additional 1 liter of the clear liquid of your choice.

While drinking a colonoscopy prep may not sound like fun, remember that it’s an essential part of a potentially lifesaving procedure. To help you through the process, this Web site provides you with helpful tips, encouragement, patient stories, and other information.

Important Safety Information about MOVIPREP

MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. MOVIPREP is contraindicated in patients with gastrointestinal (GI) obstruction, bowel perforation, gastric retention, ileus, toxic colitis or toxic megacolon, and patients who have had a severe hypersensitivity reaction to any of its components. MOVIPREP should be used with caution in patients at risk of or with fluid and electrolyte abnormalities, hyponatremia, arrhythmias, seizures, in patients with impaired renal function or patients taking concomitant medications that affect renal function, patients with known or suspected inflammatory bowel disease, patients with suspected GI obstruction or perforation, patients at risk for aspiration, and patients with glucose-6-phosphate dehydrogenase deficiency. Most common adverse reactions for split dosing (incidence ≥5%) are malaise, nausea, abdominal pain, vomiting, and upper abdominal pain. The most common adverse reactions for evening only dosing (incidence ≥5%) are abdominal distension, anal discomfort, thirst, nausea, abdominal pain, sleep disorder, rigors, hunger, malaise, vomiting, and dizziness. MOVIPREP contains 233 mg of phenylalanine per treatment. Advise patients to hydrate adequately before, during, and after the use of MOVIPREP.

You are encouraged to report negative side effects to the FDA. Visit www.fda.gov/safety/medwatch/ or call 1-800-FDA-1088.

Complete Prescribing Information pdf icon

For Dummies is a registered trademark of Wiley Publishing, Inc.

References: 1. Medi-Span® Price Rx® [database online]. Indianapolis, IN: Wolters Kluwer Health. http://www.medispan.com/drug-pricing-analysis-pricerx.aspx. Accessed July 18, 2011.
2. MoviPrep [prescribing information]. Morrisville, NC: Salix Pharmaceuticals, Inc; 2011.